Andere talen Palatin Technologies, Inc.

Aandelen

PTN

US6960775020

Beurs gesloten - Nyse Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,72 ^USD	-0,58%		-8,99%	-56,78%

08/04	Palatin kondigt klinische resultaten aan van Fase 3 Pl9643 MELODY-1 Droge Oogaandoening (Ded) gepresenteerd op American Society of Cataract and Refractive Surgery (Ascrs) 2024	CI
28/02	Sectorupdate: Gezondheidszorgaandelen dalen aan het eind van de middag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PALATIN ANNOUNCES PHASE 3 PL9643 MELODY-1 DRY EYE DISEASE CLINICAL DATA RESULTS PRESENTED AT AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY 2024	09/04
Palatin Announces Phase 3 Pl9643 Melody-1 Dry Eye Disease Clinical Data Results Presented At American Society of Cataract and Refractive Surgery 2024	08/04
PALATIN ANNOUNCES RESULTS OF PL9643 MELODY-1 PIVOTAL PHASE 3 CLINICAL TRIAL IN PATIENTS WITH DRY EYE DISEASE	29/02
Sector Update: Health Care Stocks Decline Late Afternoon	28/02
Palatin Shares Skid After Dry Eye Drug Candidate Misses Part of Targets in Late-Stage Trial	28/02
Palatin Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	14/02
PALATIN ANNOUNCES DATABASE LOCK FOR PL9643 MELODY-1 PIVOTAL PHASE 3 CLINICAL TRIAL IN PATIENTS WITH DRY EYE DISEASE	06/02
Palatin Announces Database Lock for PL9643 Melody-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease	05/02
PALATIN ANNOUNCES $10 MILLION REGISTERED DIRECT OFFERING	31/01
PALATIN PROVIDES CORPORATE UPDATE AND HIGHLIGHTS STRATEGIC PRIORITIES FOR CALENDAR YEAR 2024	09/01
Palatin Technologies, Inc. Provides Corporate Update and Highlights Strategic Priorities for Year 2024	08/01
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.	03/01
Cosette Pharmaceuticals, Inc. acquired worldwide rights to Vyleesi from Palatin Technologies, Inc. for approximately $170 million.	20/12
Top Premarket Decliners	15/12
PALATIN REPORTS FIRST QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	15/11
Palatin Technologies, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	14/11
PALATIN TO REPORT FIRST QUARTER FISCAL YEAR 2024 RESULTS, TELECONFERENCE AND WEBCAST TO BE HELD ON NOVEMBER 14, 2023	10/11
PALATIN ANNOUNCES CLOSING OF $5 MILLION REGISTERED DIRECT OFFERING	25-10-23
Palatin Technologies, Inc. announced that it has received $5.000001 million in funding	24-10-23
Palatin Technologies, Inc. announced that it expects to receive $5.000001 million in funding	23-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Palatin Technologies, Inc.

Aandelen

PTN

US6960775020

Andere talen

Filters